The vision of National TB elimination program to eliminate TB by 2025 requires holistic and intensified efforts. Intensified efforts will ensure that none of the patients fall under the radar and holistic so that we can optimally diagnose and treat not only the drug sensitive but also the drug resistant cases.
The success rate for treatment of drug sensitive patients is >80%, the challenge however lies with the Multi drug resistant (MDR) and XDR where the treatment success rate is < 50%.
Dr.Aparna Birajdar, M.D. Pulmonary Medicine from LTMMC, Sion Hospital Mumbai is a leading clinician since 2014 practicing in Pune with Sahyadri Hospitals and actively associated with NTEP as Consultant Pulmonologist under National Urban Health Mission and Pune Municipal corporation since 2017.
In this webinar she will highlight the newer diagnostic modalities available to aid in the early diagnosis and management of MDR-TB and how newer solutions will help overcome the menace of DRTB.